Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters

Figure 1

Serum levels of sCD30 in AS patients and healthy controls (HCs) were determined using a commercial enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer’s instructions (eBioscience). (a) Serum sCD30 levels in 35 AS patients and 32 healthy controls; (b) serum sCD30 concentrations in healthy male and female individuals; (c) the correlation of serum sCD30 levels with age in HCs (, ). .

(a)

(b)

(c)